Families’ experiences with pediatric immunology genomic testing: A cross-sectional survey

Abstract Genomic testing enables accurate diagnosis and tailored management of paediatric inborn errors of immunity (IEI). However, limited understanding of families' experiences and needs hinders the development of responsive models of care. This study aimed to assess families’ experiences with IEI genomic testing and psychosocial wellbeing. Eligible participants included carers of children who underwent IEI genomic testing at < 18 years between 2017–2025 in Queensland, Australia, and their adolescent/young adult (AYA) children (≥ 12 years). Cross-sectional surveys, using validated scales and purposively-designed items, captured participants’ experiences with IEI genomic testing, psychosocial wellbeing, and support needs. Cohort characteristics (carers n = 42, AYAs n = 10) were descriptively summarized and factors associated with carer psychological distress were evaluated using multivariable linear regression. High satisfaction with genomic testing was reported by carers (M:8.5/10;±2.3) and AYAs (M:8.0/10;±1.6) and carers assigned high personal utility to the results (M:4.7/7;±1.1). Over half of carers (n = 24/42) reported elevated psychological distress, with significantly higher levels among carers whose child received a positive genetic result (p < 0.05). Around half of AYAs (self- or proxy-reported) experienced difficulties across health-related quality-of-life domains and ≥ 20% of carers or AYAs reported clinically significant levels of anxiety, depression, anger and/or need for help. Participants expressed concerns about future reproductive planning (carers: n = 23/42;54%, AYAs: n = 6/10;60%) and transitioning to adult healthcare (carers: n = 9/42;21%, AYAs: n = 4/10;40%) and reported a need for condition-specific information (carers: n = 9/42;21%; AYAs n = 4/10;40%). These findings demonstrate high acceptability towards IEI genomic testing among families while highlighting the importance of tailored psychosocial and informational support.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-09
DOI
https://doi.org/10.21203/rs.3.rs-10924231/v1
Primary Topic
Immunodeficiency and Autoimmune Disorders
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Families’ experiences with pediatric immunology genomic testing: A cross-sectional survey

Alberto Pinzón‐Charry, Tatiane Yanes, Jane Peake, Peter B. McNaughton et al.
Research Square
Immunodeficiency and Autoimmune Disorders
preprint

Families’ experiences with pediatric immunology genomic testing: A cross-sectional survey

Alberto Pinzón‐Charry, Tatiane Yanes, Jane Peake, Peter B. McNaughton, Kate Hetherington, Emily DeBortoli, Larissa Vaz-Gonçalves, Aideen M McInerney-Leo, Brittany C. McGill, Anna Sullivan, Tenielle Clinch, Daniël Zwerus, Amy Clark, Sébastian de Bon, Mariana Melo, Louise Grant, Sharon Vacher, Jane Pettigrew
preprint en

Abstract

Abstract Genomic testing enables accurate diagnosis and tailored management of paediatric inborn errors of immunity (IEI). However, limited understanding of families' experiences and needs hinders the development of responsive models of care. This study aimed to assess families’ experiences with IEI genomic testing and psychosocial wellbeing. Eligible participants included carers of children who underwent IEI genomic testing at < 18 years between 2017–2025 in Queensland, Australia, and their adolescent/young adult (AYA) children (≥ 12 years). Cross-sectional surveys, using validated scales and purposively-designed items, captured participants’ experiences with IEI genomic testing, psychosocial wellbeing, and support needs. Cohort characteristics (carers n = 42, AYAs n = 10) were descriptively summarized and factors associated with carer psychological distress were evaluated using multivariable linear regression. High satisfaction with genomic testing was reported by carers (M:8.5/10;±2.3) and AYAs (M:8.0/10;±1.6) and carers assigned high personal utility to the results (M:4.7/7;±1.1). Over half of carers (n = 24/42) reported elevated psychological distress, with significantly higher levels among carers whose child received a positive genetic result (p < 0.05). Around half of AYAs (self- or proxy-reported) experienced difficulties across health-related quality-of-life domains and ≥ 20% of carers or AYAs reported clinically significant levels of anxiety, depression, anger and/or need for help. Participants expressed concerns about future reproductive planning (carers: n = 23/42;54%, AYAs: n = 6/10;60%) and transitioning to adult healthcare (carers: n = 9/42;21%, AYAs: n = 4/10;40%) and reported a need for condition-specific information (carers: n = 9/42;21%; AYAs n = 4/10;40%). These findings demonstrate high acceptability towards IEI genomic testing among families while highlighting the importance of tailored psychosocial and informational support.

Research Square
The University of Queensland (AU), UNSW Sydney (AU), Princess Máxima Center (NL), Children's Health Queensland Hospital and Health Service (AU)
Immunodeficiency and Autoimmune Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon